Euglena Q2 FY2026 Analysis: Profitability Rebounds on Non-Operating Gains
Euglena (株式会社ユーグレナ), a company focusing on health supplements and cosmetics utilizing Euglena algae, alongside developing advanced fuels for diesel and jet applications, reported solid top-line growth in its second quarter (Q2) of fiscal year 2026. The firm posted Revenue of JPY 26.5bn (+8.0% YoY) and Operating Profit of JPY 1.87bn (+14.3% YoY). Most notably, Ordinary Income surged by 45.8% YoY to JPY 1.71bn, while Net Profit swung dramatically to JPY 73M from a loss in the prior year period.
| Metric | Current Period (JPY bn) | Prior Period (JPY bn) | YoY Change |
|---|---|---|---|
| Revenue | 26.5bn | 24.553bn | +8.0% |
| Operating Profit | 1.87bn | 1.636bn | +14.3% |
| Ordinary Income | 1.71bn | 1.172bn | +45.8% |
| Net Profit | 73M | -559M | N/A YoY |
| Operating Margin | 7.1% | - | - |
| Equity Ratio | 47.8% | 42.7% | - |
Euglena leverages its proprietary Euglena algae across diverse sectors, maintaining a dual focus on high-growth health and wellness products while simultaneously advancing sustainable energy solutions for the aviation and transport fuel markets.
Business Overview & Analysis The revenue increase of 8.0% YoY was primarily driven by organic growth within the healthcare segment and expanded orders from key partners such as the Kyusai Group and Satizu Pharmaceutical Group. Operationally, the company demonstrated robust performance, with Operating Profit rising 14.3% YoY. The significant jump in Ordinary Income (+45.8% YoY) is largely attributable to the normalization of non-operating items, specifically the elimination of special losses recorded in the prior year period (related to voluntary retirement incentives).
For international investors, understanding the distinction between Japanese profit metrics is crucial. While Operating Profit reflects core business efficiency, the substantial improvement in Ordinary Income highlights the impact of financial adjustments outside daily operations. The most positive signal for stakeholders is the dramatic swing in Net Profit from a significant loss in the prior year to JPY 73M this quarter.
The company continues to emphasize a shift toward “cash flow-centric management.” Operational improvements, such as enhanced gross profit margin and increased efficiency in advertising expenditure, are being quantified through metrics like adjusted EBITDA (JPY 3.804bn). This operational strengthening supports the stated medium-term goal of achieving sustainable profitability.
Full-Year Guidance Management has not disclosed a full-year forecast at this stage.
Key Takeaways for Investors
- Profit Quality vs. Scale: While the Net Profit rebound is highly positive, investors must recognize that a significant portion of this improvement stems from the reversal of non-recurring special losses rather than solely core business expansion. The sustainability of future profitability hinges on maintaining operational efficiency improvements.
- Focus on Cash Generation: Given the reliance on temporary accounting adjustments for the bottom line, attention should remain fixed on metrics like adjusted EBITDA to gauge underlying cash-generating capability and management’s commitment to “cash flow-centric management.”
- Solvency Improvement: The Equity Ratio increased to 47.8% from 42.7%, indicating a strengthening balance sheet position with reduced reliance on debt financing, which is a key positive indicator of financial stability.
Source: Original filing (TDnet) | 日本語版
This article is for informational purposes only and does not constitute investment advice. Financial figures are AI-extracted and may contain errors — always verify against the original filing.